The EORTC Board cordially invites you to a Plenary Session in honor of Francoise Meunier
At the Crowne Plaza Brussels - Le Palace on 12 March 2015 at 16:00
After 24 years of dedicated service as EORTC Director General with a major commitment to the management of pan-European cancer research, Françoise Meunier will continue her activities from 1st April 2015 as EORTC Director Special Projects.
Program
- General introduction - Roger Stupp (CH)
- Françoise Meunier’s implication in research on “Fungal infections” - Peter Donnelly (NL)
- Françoise Meunier as EORTC Director General - Alexander Eggermont (FR)
- The patients perspectives and survival issues - Isabelle Lebrocquy (NL)
- Cancer management and transatlantic cooperation - Richard Schilsky (USA)
- The EORTC Charitable Trust - Diego du Monceau de Bergendal (BE)
- EORTC future perspectives - Roger Stupp (CH)
Followed by a reception and walking dinner at Palais d’Egmont at 19:00
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
